![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Pfizer and Mylan Delay Merger Due to COVID-19
Pfizer and Mylan Delay Merger Due to COVID-19
![Delay clock](https://www.fdanews.com/ext/resources/test/Drug-Images4/Delay-clock.gif?t=1585260318&width=430)
Mylan’s merger with Pfizer-subsidiary Upjohn has been pushed back to the second half of 2020 because of the COVID-19 outbreak.
Mylan and Upjohn are merging to form a new company called Viatris. The companies first announced the merger in July 2019, and originally aimed for it to close mid-2020.
Citing delays in the regulatory review process, the companies postponed key shareholder approval meetings from late April to June.
Upcoming Events
-
18Jul
-
21Oct